MAAT INDEX

CLAIM #23043 · EMR (EMR) · 2026Q2 earnings call · May 5, 2026 · due Sep 30, 2026

For the full year, we expect FX to be a tailwind to sales of approximately 1.5% and GAAP sales to increase approximately 4.5%.

Michael Baughman · CFO

PENDING
graded after results covering Sep 30, 2026 are reported

How to check this claim

Look at: Full-year GAAP net sales growth, fiscal 2026 vs fiscal 2025

It came true if: GAAP sales growth between 4.0% and 5.0%

Where: company income statement / full-year earnings release (FY2026 10-K or Q4 earnings press release)

In context

Electric Co. expects to grow approximately 5% in Q3 and 3% for the full year. Excluding the impact of software contract renewals, Emerson Electric Co.’s growth rate is expected to be 4% for the full year. Please turn to Slide 12 for details on our Q3 and full-year 2026 guidance. Before going through the details, I would like to highlight a few important assumptions embedded in our guidance. Our guidance considers a gradual resumption of activity in the Middle East and assumes the impact of the conflict remains in the region. Additionally, we expect a net neutral impact from the removal of IEBA tariffs, as this benefit is offset by increases in Section 1 and 232 tariffs as well as freight costs. Finally, our earnings and cash flow guidance excludes any benefit of potential tariff refunds. For the full year, we expect FX to be a tailwind to sales of approximately 1.5% and GAAP sales to increase approximately 4.5%. We still expect adjusted segment EBITDA margin of approximately 28% and free cash flow of $3.5 billion to $3.6 billion. We are raising the bottom and midpoint of our 2026 adjusted EPS guide and now expect $6.45 to $6.55. We still expect to return approximately $2.2 billion to shareholders through $1.2 billion in dividends and $1.0 billion of share repurchase, of which we completed $542 million in the first half. Moving to the third quarter, sales growth is expected to be approximately 5.5% with underlying sales growth of approximately 5%. We expect adjusted segment EBITDA margin of approximately 28% and adjusted EPS of $1.65 to $1.70. With that, I would like to turn the call back to the operator for Q&A. Operator: We will now open the call for questions. Thank you. Our first question is f

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2026Q2 earnings call.